American National Registered Investment Advisor’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.29M Sell
17,628
-292
-2% -$19.6K 0.46% 59
2021
Q4
$1.12M Sell
17,920
-1
-0% -$59 0.37% 73
2021
Q3
$1.06M Sell
17,921
-32
-0.2% -$2.11K 0.38% 75
2021
Q2
$1.2M Sell
17,953
-71
-0.4% -$4.63K 0.43% 67
2021
Q1
$1.14M Sell
18,024
-83
-0.5% -$5.16K 0.44% 62
2020
Q4
$1.12M Hold
18,107
0.45% 64
2020
Q3
$1.09M Hold
18,107
0.5% 56
2020
Q2
$1.06M Hold
18,107
0.53% 56
2020
Q1
$1.01M Hold
18,107
0.63% 46
2019
Q4
$1.16M Buy
18,107
+12,287
+211% +$704K 0.57% 53
2019
Q3
$295K Buy
+5,820
New +$274K 0.16% 177

Other funds holding BMY

American National Registered Investment Advisor's BMY Position: Q1 2022 in Review

American National Registered Investment Advisor reduced its Bristol-Myers Squibb (BMY) stake by 1.6% in Q1 2022, selling an estimated $19.6K and leaving 17,628 shares worth $1.29M. The position accounts for 0.46% of the portfolio, ranked #59.

American National Registered Investment Advisor first reported a position in BMY in Q3 2019 and has held it in 11 quarters since. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

  • American National Registered Investment Advisor held 17,628 shares of Bristol-Myers Squibb worth $1.29M as of Q1 2022.
  • American National Registered Investment Advisor sold 292 Bristol-Myers Squibb shares in Q1 2022, an estimated $19.6K.
  • Bristol-Myers Squibb made up 0.46% of American National Registered Investment Advisor's portfolio in Q1 2022, its #59 holding.
  • American National Registered Investment Advisor first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 11 quarters since.
  • 2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on American National Registered Investment Advisor's 13F filing for Q1 2022, filed 13 May 2022.